PubMed

Immune thrombocytopenia associated with efalizumab therapy for psoriasis.

Warkentin TE, Kwon P.

Ann Intern Med. 2005 Nov 15;143(10):761-3. No abstract available. PMID: 16287807 [PubMed - indexed for MEDLINE]Related articlesFree article

Efalizumab-associated thrombocytopenia.

Hostetler SG, Zirwas M, Bechtel MA.

J Am Acad Dermatol. 2007 Oct;57(4):707-10. Epub 2007 Jul 16.PMID: 17637485 [PubMed - indexed for MEDLINE]Related articles

Efalizumab-induced autoimmune pancytopenia.

Tom WL, Miller MD, Hurley MY, Suneja T, Kudva G, Leonardi CL, Obadiah JM.

Br J Dermatol. 2006 Nov;155(5):1045-7.PMID: 17034539 [PubMed - indexed for MEDLINE]Related articles

Efalizumab-induced immune thrombocytopenia during retreatment.

Fargnoli MC, Tabilio A, Coletti G, Peris K.

J Am Acad Dermatol. 2008 May;58(5 Suppl 1):S125-7. No abstract available. PMID: 18489048 [PubMed - indexed for MEDLINE]Related articles

Dermatitis during efalizumab treatment in a patient with psoriasis vulgaris.

de Groot M, de Rie MA, Bos JD.

Br J Dermatol. 2005 Oct;153(4):843-4. No abstract available. PMID: 16181475 [PubMed - indexed for MEDLINE]Related articles

Efalizumab-induced aseptic meningitis.

Kluger N, Girard C, Gonzalez V, Guillot B, Bessis D.

Br J Dermatol. 2007 Jan;156(1):189-91. No abstract available. PMID: 17199599 [PubMed - indexed for MEDLINE]Related articles

[Efalizumab]

Descamps V.

Ann Dermatol Venereol. 2006 Aug-Sep;133(8-9 Pt 1):666-78. Review. French. PMID: 17053736 [PubMed - indexed for MEDLINE]Related articles

Multiple eruptive dermatofibromas in a patient receiving efalizumab.

Santos-Juanes J, Coto-Segura P, Mallo S, Galache C, Soto J.

Dermatology. 2008;216(4):363. Epub 2008 Feb 22. No abstract available. PMID: 18292655 [PubMed - indexed for MEDLINE]Related articles

Efalizumab-induced lupus-like syndrome.

Durox H, Sparsa A, Loustaud-Ratti V, Prey S, Gondran G, Manea P, Vidal E, Bedane C.

Acta Derm Venereol. 2008;88(3):270-1. No abstract available. PMID: 18480928 [PubMed - indexed for MEDLINE]Related articles

Efalizumab-associated papular psoriasis: an adverse reaction to efalizumab in three cases.

Antonucci A, Bardazzi F, Balestri R, Patrizi A.

J Dermatolog Treat. 2009;20(1):61-2.PMID: 18618361 [PubMed - indexed for MEDLINE]Related articles

Transitioning patients from efalizumab to alternative psoriasis therapies: findings from an open-label, multicenter, Phase IIIb study.

Menter A, Hamilton TK, Toth DP, Leung HM, Wetherill G, Hennessey B, Garovoy M, Kwon P, Pariser DM; Efalizumab Study Group.

Int J Dermatol. 2007 Jun;46(6):637-48.PMID: 17550570 [PubMed - indexed for MEDLINE]Related articles

Hepatitis: a rare, but important, complication of infliximab therapy for psoriasis.

Wahie S, Alexandroff A, Reynolds NJ.

Clin Exp Dermatol. 2006 May;31(3):460-1. No abstract available. PMID: 16681606 [PubMed - indexed for MEDLINE]Related articles

Efalizumab (Raptiva) for treatment of psoriasis.

[No authors listed]

Med Lett Drugs Ther. 2003 Dec 8;45(1171):97-8. No abstract available. Erratum in: Med Lett Drugs Ther. 2004 Jan 19;46(1174):8. PMID: 14657802 [PubMed - indexed for MEDLINE]Related articles

Severe neutrophilia induced by infliximab for psoriasis.

de Oliveira JP, Levy A, Morel P, Guibal F.

Br J Dermatol. 2008 Jan;158(1):200-1. Epub 2007 Nov 19. No abstract available. PMID: 18028489 [PubMed - indexed for MEDLINE]Related articles

Potential complications associated with the use of biologic agents for psoriasis.

Zeichner JA, Lebwohl M.

Dermatol Clin. 2007 Apr;25(2):207-13, vii. Review.PMID: 17430757 [PubMed - indexed for MEDLINE]Related articles

Development of primary varicella infection during infliximab treatment for psoriasis.

Balato N, Gaudiello F, Balato A, Ayala F.

J Am Acad Dermatol. 2009 Apr;60(4):709-10. No abstract available. PMID: 19293027 [PubMed - indexed for MEDLINE]Related articles

Biologicals in the treatment of psoriasis.

Boker A, Kimball AB, Rolz-Cruz G.

Curr Opin Investig Drugs. 2007 Nov;8(11):939-46. Review.PMID: 17979028 [PubMed - indexed for MEDLINE]Related articles

[New systemic treatments for psoriasis: etanercept, infliximab, adalimumab, efalizumab and alefacept]

Bos WE, Thio HB, Neumann HA, van der Fits L, Prens EP.

Ned Tijdschr Geneeskd. 2006 May 13;150(19):1065-70. Review. Dutch. PMID: 16733982 [PubMed - indexed for MEDLINE]Related articles

Two cases of atopic dermatitis-like conditions induced in psoriasis patients treated with infliximab.

Vestergaard C, Deleuran M, Kragballe K.

J Eur Acad Dermatol Venereol. 2007 Oct;21(9):1272-4. No abstract available. PMID: 17894730 [PubMed - indexed for MEDLINE]Related articles

Effective management of psoriasis symptom worsening during efalizumab therapy without discontinuing treatment: a case study.

Gisondi P, Giglio MD, Girolomoni G.

J Dermatolog Treat. 2006;17(3):172-5.PMID: 16854760 [PubMed - indexed for MEDLINE]Related articles